Schedule 13G ownership disclosure

AEGLEA BIOTHERAPEUTICS INC

Security class unavailable · CUSIP: 00773J103

Event date: 2022-11-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001319244-22-000177
Form type
SC 13G
Filer
Spyre Therapeutics, Inc.
CIK
CIK 1636282
Filed
Dec 01, 2022
Reporting period
Nov 23, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub